IgA Nephropathy Epidemiology

View All

iga-nephropathy-treatment-market-size-share-trends-growth-cagr-companies-analysis
IgA Nephropathy – Navigating the Emerging Therapies and Key Companies in the Therapeutics Domain

IgA Nephropathy (IgAN), also called Berger’s disease, is an autoimmune rare disease affecting the kidneys. It impairs blood filtration in the kidneys' tiny blood channels. An aberrant protein destroys the filtering unit (glomerulus) inside the kidneys, causing IgA Nephropathy. It is estimated that 20–40% of persons...

Find More

IgA Nephopathy Market | IgAN Market
Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the IgA Nephropathy Market Share Growth

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. Factors such as population aging, lifestyle-modifiable risk factors, a decline in early-life infectious diseases, sedentary lifestyle, unhealthy food habits have resulted in the emergence of chronic diseases as a major global hea...

Find More